NPPB and COVID-19: Zwaenepoel et al. concludes that hs-TnI and NT-proBNP outperform other routinely used biomarkers (C-reactive protein, D-dimer and ferritin), as well as clinical indices of disease severity in ICU, such as total SOFA, respiratory SOFA and P/F ratio in critically ill COVID-19 patients [46].